Gene Therapy for the Heart Lessons Learned and Future Perspectives

Area of Science:

• Cardiovascular Research
• Molecular Medicine
• Gene Therapy

Background:

• Clinical gene therapy has achieved success in various fields, with numerous products approved or in late-stage trials.
• Despite advancements, no gene therapy approach has proven effective for cardiac conditions.

Purpose of the Study:

• To review past cardiac gene therapy clinical trials for therapeutic angiogenesis and heart failure modulation.
• To critically assess the successes and failures in cardiac gene therapy.
• To identify future promising areas in cardiac gene therapy development.

Main Methods:

• Review of clinical trial data for cardiac gene therapy.
• Analysis of challenges in cardiac gene delivery and therapeutic outcomes.
• Evaluation of advancements in gene expression modulation and gene editing.

Main Results:

• Inefficient cardiac gene delivery is a primary obstacle to successful gene therapy for heart disease.
• Past trials focused on inducing angiogenesis and modulating cardiac function in ischemic hearts and heart failure.
• Improvements are needed in animal models, gene selection, clinical trial design, and understanding cardiac biology.

Conclusions:

• Future cardiac gene therapy holds promise through small RNA therapeutics and precise gene editing.
• These advancements may enable cardiac regeneration after myocardial infarction and gene correction for inherited cardiomyopathies.
• Overcoming delivery efficiency hurdles is crucial for realizing the potential of cardiac gene therapy.